Skip to main content
. 2012 Feb 28;3(1):66–76.

Table 1.

Descriptive statistics of study population by vital status.

Alive (N=37,076) All-cause Death (N=7,381) Cancer specific Death (N=2,245) Circulatory disease Death (N=3,276)

  n(%) n(%) n(%) n(%)
Mean Age (years) (SD) 60.46 (7.87) 69.99 (10.28) 66.50 (9.45) 71.72 (10.03)
Gender        
Men 18899 (50.97) 3987 (54.02) 1245 (55.46) 1843 (56.26)
Women 18177 (49.03) 3394 (45.98) 1000 (44.54) 1433 (43.74)
SES        
White collar 16302 (43.97) 2088 (28.89) 817 (36.39) 840 (25.64)
Blue collar 15460 (41.70) 2111 (28.60) 770 (34.30) 854 (26.07)
Not gainfully employed/Missing 5314 (14.33) 3182 (43.11) 658 (29.31) 1582 (48.29)
Charlson Comorbidity Index        
0 31574 (85.16) 4523 (61.28) 1499 (66.77) 1874 (57.20)
1 2790 (7.53) 1142 (15.47) 203 (9.04) 623 (19.02)
2 1997 (5.39) 1026 (13.90) 388 (17.28) 419 (12.79)
3 464 (1.25) 341 (4.62) 75 (3.34) 180 (5.49)
4+ 251 (0.68) 349 (4.73) 80 (3.56) 180 (5.49)
Cancer prior to measurement 905 (2.44) 936 (12.68) 433 (19.29) 325 (9.92)
Circulatory disease prior to measurement 5246 (14.15) 2227 (30.17) 460 (20.49) 1265 (38.61)
Mean follow-up time (years) (SD) 9.51 (2.82) 5.56 (3.61) 5.58 (3.59) 5.39 (3.62)
CRP (mg/l)        
Mean (SD) 5.27 (9.56) 7.82 (18.16) 8.30 (19.55) 7.42 (16.31)
>10 2041 (5.50) 912 (12.36) 283 (12.61) 402 (12.27)
Albumin (g/l)        
Mean (SD) 42.57 (2.60) 41.17 (2.98) 41.26 (3.05) 41.19 (2.83)
<35 61 (0.16) 138 (1.87) 47 (2.09) 46 (1.40)
HDL-cholesterol (mmol/L)        
Mean (SD) 1.55 (0.43) 1.47 (0.45) 1.49 (0.44) 1.42 (0.45)
<1.03 3680 (9.93) 1154 (15.63) 304 (13.54) 600 (18.32)
Gamma-glutamyltransferase (U/L)        
Mean (SD) 34.61 (42.00) 46.60 (94.54) 48.13 (106.50) 41.80 (59.86)
>36 10009 (27.00) 2309 (31.28) 663 (29.53) 1048 (31.99)
Mortality score        
0 23772 (64.12) 3975 (53.85) 1273 (56.70) 1700 (51.89)
1 11039 (29.77) 2480 (33.60) 706 (31.45) 1137 (34.71)
2 2048 (5.52) 762 (10.32) 214 (9.53) 363 (11.08)
3 212 (0.57) 147 (1.99) 45 (2.00) 71 (2.17)
4 5 (0.01) 17 (0.23) 7 (0.31) 5 (0.15)